This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Practice Guidelines

Andrew H. Soll, MD; Practice Parameters Committee of the American College of Gastroenterology; James L. Achord, MD; Gene Bozymski, MD; Scott Brooks, MD; Frank Lanza, MD; David Lyon, MD; George Meyer, MD; John Reinus, MD; Marvin Schuster, MD; James Achord, MD; Josh Ofman, MD; Peter Glassman, MD; Loren Laine, MD; Guido Tytgat, MD, PhD; J. H. Walsh, MD; David Y. Graham, MD; W. L. Peterson

JAMA. 1996;275(8):622-629.

Abstract
Objective.
—To integrate the realization that peptic ulcer most commonly reflects infection with Helicobacter pylori or use of aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs) into a disease management approach.

Participants.
—Guidelines were outlined by the author and presented for review to the American College of Gastroenterology (ACG) Practice Parameters Committee, selected by the president of the ACG, and a panel of experts in peptic ulcer, selected by the committee.

Evidence and Consensus Process.
—These guidelines were formulated following extensive review of the literature obtained by a MEDLINE search and presented for detailed review and revision to unpublicized committee meetings on three occasions and to experts by mail. These recommendations are an official statement of the ACG and have been approved by the American Gastroenterological Association and the American Society for Gastroenterological Endoscopy. Firm recommendations are discriminated from reasonable suppositions pending definitive data.

Conclusions.
—Since cure of H pyloriinfection decreases recurrence rates and facilitates healing, antibiotic therapy is indicated for all H pylori—infected ulcer patients. No optimal, simple antibiotic regimen has yet emerged. Simultaneous conventional ulcer therapy is recommended to facilitate symptom relief and healing. For refractory ulcers, only maximal acid inhibition offers advantage over continued conventional therapy; cure of H pylori infection is likely to facilitate healing of refractory ulcers. Only with complicated or refractory ulcers should conventional maintenance therapy be continued, at least until successful H pylori eradication is confirmed. A search for NSAID use is indicated for all ulcer patients. For NSAIDassociated ulcers these drugs should be discontinued if possible and H pylori, if present, should be cured.

(JAMA. 1996;275:622-629)

Author Affiliations
From the CURE Digestive Disease Research Center, Bldg 115, Room 215, West Los Angeles Veterans Affairs Medical Center, Los Angeles, Calif (Dr Soll).

Footnotes
A complete list of the members of the Practice Parameters Committee appears at the end of the article.

Corresponding author: Andrew H. Soll, MD, CURE Digestive Disease Research Center, Bldg 115, Room 215, West Los Angeles Veterans Affairs Medical Center, Los Angeles, CA 90073.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis
Spiegel et al.
ANN INTERN MED 2003;138:795-806.
ABSTRACT | FULL TEXT  

Helicobacter pylori susceptibility testing by disc diffusion
McNulty et al.
J Antimicrob Chemother 2002;49:601-609.
ABSTRACT | FULL TEXT  

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Choudhry et al.
JAMA 2002;287:612-617.
ABSTRACT | FULL TEXT  

Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis
Fischbach et al.
Int J Epidemiol 2002;31:128-139.
ABSTRACT | FULL TEXT  

Process of Care and Outcomes for Elderly Patients Hospitalized With Peptic Ulcer Disease: Results From a Quality Improvement Project
Brock et al.
JAMA 2001;286:1985-1993.
ABSTRACT | FULL TEXT  

Improving Care for Elderly Patients With Peptic Ulcer Disease: Should the Focus Be on Drugs or Bugs?
Butler et al.
JAMA 2001;286:2023-2024.
FULL TEXT  

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
van Zanten et al.
CMAJ 2000;162:s3-23.
ABSTRACT | FULL TEXT  

Helicobacter pylori-Related Disease: Guidelines for Testing and Treatment
Peterson et al.
Arch Intern Med 2000;160:1285-1291.
ABSTRACT | FULL TEXT  

The Very Model of a Modern Etiology: A Biopsychosocial View of Peptic Ulcer
Levenstein
Psychosom. Med. 2000;62:176-185.
ABSTRACT | FULL TEXT  

Regular review: Treatment of Helicobacter pylori infection
de Boer and Tytgat
BMJ 2000;320:31-34.
FULL TEXT  

Lack of Effect of Treatment for Helicobacter pylori on Symptoms of Nonulcer Dyspepsia
Greenberg and Cello
Arch Intern Med 1999;159:2283-2288.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial of an Enhanced Patient Compliance Program for Helicobacter pylori Therapy
Lee et al.
Arch Intern Med 1999;159:2312-2316.
ABSTRACT | FULL TEXT  

Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis
Jaakkimainen et al.
BMJ 1999;319:1040-1044.
ABSTRACT | FULL TEXT  

Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease
Lai et al.
Fam Pract 1999;16:483-488.
ABSTRACT | FULL TEXT  

Clinical and Economic Effects of Population-Based Helicobacter pylori Screening to Prevent Gastric Cancer
Fendrick et al.
Arch Intern Med 1999;159:142-148.
ABSTRACT | FULL TEXT  

Screening for Helicobacter pylori and Nonsteroidal Anti-inflammatory Drug Use in Medicare Patients Hospitalized With Peptic Ulcer Disease
Hood et al.
Arch Intern Med 1999;159:149-154.
ABSTRACT | FULL TEXT  

Amoxycillin tolerance in Helicobacter pylori
Dore et al.
J Antimicrob Chemother 1999;43:47-54.
ABSTRACT | FULL TEXT  

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database
Bashford et al.
BMJ 1998;317:452-456.
ABSTRACT | FULL TEXT  

Treatment of Helicobacter pylori Infection
Salcedo and Al-Kawas
Arch Intern Med 1998;158:842-851.
ABSTRACT | FULL TEXT  

A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
Yeomans et al.
NEJM 1998;338:719-726.
ABSTRACT | FULL TEXT  

Lack of Evidence for an Association Between Heliobacter pylori Infection and the Anorexia of Aging-Reply
Portnoi
Arch Intern Med 1997;157:1772-1773.
ABSTRACT  

Time Trends of Physician Visits and Treatment Patterns of Peptic Ulcer Disease in the United States
Munnangi and Sonnenberg
Arch Intern Med 1997;157:1489-1494.
ABSTRACT  

Diagnosis and Treatment of Helicobacter pylori Infection Among California Medicare Patients
Roll et al.
Arch Intern Med 1997;157:994-998.
ABSTRACT  

Pharmacoeconomic Comparison of Treatments for the Eradication of Helicobacter pylori
Taylor et al.
Arch Intern Med 1997;157:87-97.
ABSTRACT  

Practice Guidelines for Treatment of Peptic Ulcer Disease
Fennerty
JAMA 1996;276:1135-1135.
ABSTRACT  

Practice Guidelines for Treatment of Peptic Ulcer Disease
Webb
JAMA 1996;276:1136-1136.
ABSTRACT  

Practice Guidelines for Treatment of Peptic Ulcer Disease
Olson
JAMA 1996;276:1135-1136.
ABSTRACT  

Practice Guidelines for Treatment of Peptic Ulcer Disease
Tsang and Rotterdam
JAMA 1996;276:1136-1136.
ABSTRACT